HOME >> MEDICINE >> NEWS
Common cold no more frequent in people with asthma - but symptoms are more severe

N.B. Please note that if you are outside North America the embargo date for Lancet press material is 0001hours UK time Friday 8th March 2002.

People with asthma are not at an increased risk of having a common cold, but are more likely to develop more severe respiratory symptoms if infected with the cold virus, conclude authors of a UK study in this weeks issue of THE LANCET.

Rhinoviruses are the most frequent cause of the common cold. It has long been thought that people with asthma are more susceptible to colds than people without the disease. Jonathan Corne from Queens Medical Centre, Nottingham, UK, and colleagues did a study to investigate whether people with asthma are more susceptible to rhinoviruses, and to compare the effects of rhinovirus infection between people with or without asthma.

76 cohabiting couples were recruited to the study. One person in every couple had atopic asthma and the other did not. Participants completed daily diary cards of upper-respiratory-tract (URT) and lower-respiratory-tract (LRT) symptoms. They also measured their peak expiratory flow from the lungs twice daily. Nasal secretions were examined for rhinovirus every two weeks.

753 nasal samples were assessed. Rhinovirus was detected in around 10% (38/378) of samples from participants with asthma and 8.5% (32/375) of samples from healthy participants. However, after adjustment for confounding factors, asthma did not significantly increase the risk of infection. Rhinovirus infection was associated more frequently with LRT infection in participants with asthma than in healthy individuals (12 of 28 infections compared with four of 23). Symptoms of LRT associated with rhinovirus infection were substantially more severe and longer-lasting in participants with asthma than in healthy participants. The two groups did not differ in frequency, severity, or duration of URT infections or symptoms associated with rhinovirus infection.

Jo
'"/>

Contact: Richard Lane
richard.lane@lancet.com
44-0-20-7424-4949
Lancet
7-Mar-2002


Page: 1 2

Related medicine news :

1. Common anesthetics appear safe for developing fetal brain
2. Common schizophrenia symptoms often overlooked by physicians, according to expert panel
3. Common antidepressants lower effects of tamoxifen in many women
4. Common antidepressant may affect youths bone development
5. Common epilepsy treatment to be used for bulimia nervosa
6. Mouth sores: Common complaints of students
7. Common drug, given promptly, reduces incidence of post-traumatic stress disorder, small study finds
8. New Commonwealth Fund analysis compares candidtes health care reform proposals
9. Common heart surgery potentially dangerous
10. Common treatment for cancer pain stimulates breast tumor growth in mice
11. Common diabetes drug causes arteries to spasm, endangering heart

Post Your Comments:
(Date:10/20/2014)... Ohio (PRWEB) October 20, 2014 Unveiled at ... new Strategic Direction Scorecard conservatively estimates member hospital ROI on ... spent on dues, The Center provides $12.50 in value to ... is (Member Value – Member Dues)/Member Dues. , “This ... at this number and we think the methodology is really ...
(Date:10/20/2014)... Houston plastic surgeon Dr. Christopher Patronella ... innovative True Form Tummy Tuck® method as ... at The University of Texas Medical Branch in ... medical student. Patronella, who is a founding partner of ... in Texas, The Aesthetic Center for Plastic Surgery ...
(Date:10/19/2014)... The leading review website, Top10BestSEOHosting.com, has recently announced ... the best Dedicated Server Hosting suppliers. Their websites ... buy high quality hosting and save money at ... Top10BestSEOHosting.com says, “We believe that iPage and GreenGeeks ... lot of the global clients enjoy using their ...
(Date:10/19/2014)... (PRWEB) October 20, 2014 This ... for Partial Seizure, complete with comparative analysis at ... of action (MoA), route of administration (RoA) and ... news and press releases. It also reviews key ... Seizure and special features on late-stage and discontinued ...
(Date:10/19/2014)... Recently, Fancyflyingfox.com, an innovative company that ... announced its latest designs of 2014 mother of ... elegant outfits are offered with big discounts, up to ... October 30 can enjoy this special offer. , ... it has become one of the leading brands in ...
Breaking Medicine News(10 mins):Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4Health News:Plastic Surgeon Patronella Presents Artistically-Inspired Tummy Tuck Method to Future Generation of Plastic Surgeons in Texas 2Health News:Top10BestSEOHosting.com Considers iPage And GreenGeeks As The Best Dedicated Server Hosting Suppliers 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 4Health News:Fancyflyingfox.com Updates Its Website With New Mother Of The Bride Dresses For 2014 2
(Date:10/20/2014)... --  BioNano Genomics announced today achievement of a major ... data at 30X depth, sufficient for a genome map, in ... established and demonstrated for the IrysChip TM V2, the ... and will be rolled out to BioNano,s collaborators and customers ... advancement at the American Society for Human Genetics (ASHG) ...
(Date:10/20/2014)... 2014 Lpath, Inc. (NASDAQ: ... therapeutics, received official notification from the European Patent Office ... patent supporting its iSONEP™ and ASONEP™ programs. ... No. 2087002, claims compositions of matter related to ... compounds, iSONEP and ASONEP. Sonepcizumab is an antibody ...
(Date:10/20/2014)... Norgine B.V. today announced that the Phase ... NER1006, presented at the 79 th Annual Scientific ... Philadelphia, PA , has met its primary ... of cleansing success. The study demonstrated high quality bowel ... screening colonoscopy patients. [1] (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a) ...
Breaking Medicine Technology:BioNano Genomics Announces One Human : One Chip : One Day 2BioNano Genomics Announces One Human : One Chip : One Day 3Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 2Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 3Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 4Positive Results from Phase II Data Show NER1006 Achieves High Quality Bowel Cleansing Efficacy 2
Cached News: